AptarGroup (ATR) Receives FDA 510(k) Clearance for HeroTracker Sense

AptarGroup, Inc. (NYSE:ATR) is one of the Best 52-Week Low Mid Cap Stocks to Buy Now. On October 16, AptarGroup, Inc. (NYSE:ATR) announced receiving FDA 510(k) clearance for HeroTracker Sense as a Class II medical device.

HeroTracker Sense is a Bluetooth-enabled small sensor that can be attached to inhalers. The device connects the inhaler with a smartphone application that sends reminders, offers educational tips, and provides real-time feedback.

Following the FDA approval, on October 17, Matt Roberts from Raymond James reiterated a Buy rating on AptarGroup, Inc. (NYSE:ATR) with a price target of $172.

AptarGroup, Inc. (NYSE:ATR) designs and manufactures dosing, dispensing, and protection technologies for various products.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.